http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 한오석 ( Oh Suk Hahn ) (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
피부사장균증(皮膚絲狀菌症) 치료(治療)를 위한 경구용(經口用) 항진균제(抗眞菌濟)의 비용(費用)-효과(效果) 분석(分析)
양봉민 ( Bong Min Yang ),노병인 ( Byung In Ro ),이태진 ( Tae Jin Lee ),한오석 ( Oh Suk Hahn ),정현진 ( Hyun Jin Jeong ) 한국보건경제정책학회(구 한국보건경제학회) 2001 보건경제와 정책연구 Vol.7 No.1
Onychomycosis is a relatively common condition, which accounts for more than one thirds of al superficial fungal infections. It`s not merely a cosmetic problem because patients with this disabuse experience physical, psychological, and even social limitations to various degrees. This study conducted a cost-effectiveness analysis from a third-party payer`s perspective, comparing five popular oral therapies for dermatophytosis of toenails: itraconazole-continuous, itraconazole-pulse, terbinafine, fluconazole, and ketoconazole. A dermatologist`s proven analytic decision tree was used in the whole process of estimating costs and effectiveness of each drug. Symptom-free days during a predetermined time span (36months) were the main estimator of effectiveness and a comprehensive meta-analysis of published clinical efficacy data served as the statistical input in calculating them. For determination of the medical practice cost of each comparator, two kinds of costs based on both standard practice guideline(confirmed by an experienced dermatologist) and customary practice pattern(revealed by National Health Insurance claims data of Korea) were considered respectively. As a result, in both cases itraconazole-pulse was found the most cost-effective therapy(on the basis of cost per symptom-free days) in Korea followed by terbinafine. In addition, the difference in cost-effectiveness ratio between itraconazole-pulse and terbinafine was widened even more in the case of customary practice cost being used because of their disparity in prescription and follow-up visit requirements, influenced by doctors` economic incentives.
-
양봉민,백승운,최문석,이덕희,한오석 한국보건경제학회 2000 보건경제와 정책연구 Vol.6 No.2
Hepatitis B (HBV) infection is endemic in Korea. Vaccination programs introduced in 1983 have reduced the prevalence of HBV in people aged less than 20 years to 2.8%(Ahn YO. 1996). however, there will be significant morbidity due to HBV for the next 15-30 years until the real benefit of the vaccination programs take effect. This study investigates the 1) the total direct medical costs and 2) the indirect costs associated with HBV in South Korea in 1997. Medical literature and other published data were used to gain an understanding of HBV: its epidemiology and disease progression. The Korean medical insurance database, patient records, patient questionnaires, and expert opinion were used as sources of data. Direct and indirect costs for prevention. acute infection, chronic infection, cirrhosis, and liver cancer were estimated. HBV related morbidity and mortality are a significant cost burden to the Korean healthcare system. In 1997, the total direct and indirect costs of HBV related diseases are 4.47 of national health expenditures. The direct costs alone are 3.11% of the national healthcare expenditure (NHE). This is similar to the expenditure in developed countries for diseases such as diabetes and asthma. The greatest components of the direct costs are the cost of in-patient and outpatient care. The results of this study confirm the importance of the vaccination program in Korea. An effective vaccination program will lead to huge cost savings if infection rates can be minimized. However, while large percentage of the population is infected with HBV, preventing disease progression also has potential cost benefits.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
